COMUNICADO: Liver Cancer Researchers from AP-HP and Singapore Collaborate on a Prospective Meta-Analysis of Two Studies of Y-90 resi

 
Consulta el estado del tiempo
Consulte el estado del Tráfico y del Tiempo para estos días >>
Consulta el estado del tráfico

COMUNICADO: Liver Cancer Researchers from AP-HP and Singapore Collaborate on a Prospective Meta-Analysis of Two Studies of Y-90 resi

Publicado 06/10/2016 9:01:56CET

Singapore Clinical Research Institute (SCRI) is a National Academic Research Organisation dedicated to enhance the standards of human clinical research. Its mission is to spearhead and develop core capabilities, infrastructure and scientific leadership for clinical research in Singapore. SCRI is a national clinical trials coordination centre that works with National Medical Research Council (NMRC) to assist the Ministry of Health in implementing clinical trials policy and strategic initiatives to support and develop clinical research competencies locally.

In driving towards its vision, SCRI collaborates with clinicians to enhance Singapore's clinical research and strengthen its expertise in executing multi-site, multi-national studies and the development of regional clinical research networks. SCRI is a wholly-owned subsidiary of MOH Holdings. For more information, visit the SCRI website at http://www.scri.edu.sg

Photo:
http://photos.prnewswire.com/prnh/20160930/413925LOGO

http://photos.prnewswire.com/prnh/20160930/413926LOGO

http://photos.prnewswire.com/prnh/20160930/413927LOGO

http://photos.prnewswire.com/prnh/20160930/413928LOGO

CONTACT: Contact: Gillian Tan, +65 6236 9529, gillian.tan@nccs.com.sg;Valérie Vilgrain. +33 140 87 53 58, valerie.vilgrain@aphp.fr

Mejora la comunicación de tu empresa con Europa Press Comunicación

Este sitio web utiliza cookies propias y de terceros, puedes ver nuestra política de cookies -
Uso de cookies